drugset / Trial / NCT01905904

Sevoflurane in Electroconvulsive Therapy

NCT01905904 ↗

Phase 4 Completed 25 enrolled Inonu University
RandomizedCrossoverTriple-blindTreatment

Summary

The purpose of the study was to investigate the effects of different doses of sevoflurane used in electroconvulsive therapy (ECT) on duration of seizure, hemodynamic response and recovery profiles

Timeline

Start
2013-03
Primary completion
2013-05
Completion
2013-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Sevoflurane Other / unclassified 4 % —
Comparator Sevoflurane Other / unclassified 7 % —

Indications

No indication recorded.